A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2002
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/04/2002	EP0638092B1 Synthetic peptide vaccines for dental caries
12/04/2002	EP0517817B1 Inhibitors of catalytic antibodies
12/04/2002	CN1383450A Antibody molecules having specificity for huamn tumor necrosis factory alpha, and use thereof
12/04/2002	CN1383384A Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof
12/04/2002	CA2384907A1 Methods and compositions relating to mek5 and cardiac hypertrophy and dilated cardiomyopathy
12/03/2002	US6489453 Chandra: a TH1-specific gene
12/03/2002	US6489448 Antibody to a protein with thiol specific antioxidant (tsa) activity; vaccines
12/03/2002	US6489441 Transcriptional co-repressor that interacts with nuclear hormone receptors
12/03/2002	US6489418 Preparation and application of artificial anti-idiotypic imprints
12/03/2002	US6489144 Culturing cells that overproduce double-stranded-rna-dependent kinase and treatment with inducer
12/03/2002	US6489126 To identify rheumatoid arthritis (ra), and also prepare reagents for the clinical diagnosis thereof
12/03/2002	US6489122 Chlamydia pneumoniae antigenic polypeptides, which comprise polypeptide a containing a sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1, dnas encoding the antigenic polypeptides, or dnas complementary thereto;
12/03/2002	US6489118 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies
12/03/2002	US6489101 Breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast tumor protein, or a t cell that
12/03/2002	US6488937 Allergy treatment method using a rapid immunotherapy protocol
12/03/2002	US6488936 Glycoprotein d of herpes simplex type i and type ii
12/03/2002	US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively
12/03/2002	US6488934 Hepatitis B vaccine
12/03/2002	US6488933 Preparations for the treatment of T cell mediated diseases
12/03/2002	US6488932 Method for treating cancer by administering MAGE-derived peptides
12/03/2002	US6488931 Immunotherapy
12/03/2002	US6488930 Antibody or functional fragment thereof which binds to a mammalian (e.g., human) cc-chemokine receptor 4 (ccr4)
12/03/2002	US6488929 Candida albicans phosphomannan complex as a vaccine
12/03/2002	US6488926 Dna sequence encoding a fusion protein of the formula tetc-(z)a -het, wherein tetc is the c fragment of tetanus toxin, het is a heterologous protein, z is an amino acid
12/03/2002	CA2284077C Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2060544C Recombinant antibodies specific for a growth factor receptor
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
12/03/2002	CA2035474C Vaccine protecting against pig haemophilosis
12/03/2002	CA2030689C Barbiturate assay compositions and methods
11/2002
11/28/2002	WO2002095410A1 Adherent entities and uses therefor
11/28/2002	WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095048A2 Methods for genetic immunization
11/28/2002	WO2002095040A1 Delections in arterivirus replicons
11/28/2002	WO2002095027A2 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	WO2002095023A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002	WO2002095005A2 Therapeutic dna vaccination
11/28/2002	WO2002094994A2 Chimeric antigen-specific t cell-activating polypeptides
11/28/2002	WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002	WO2002094866A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	WO2002094858A1 Antiviral compounds derived from the non-glycosylated central subdomain of respiratory syncytial virus (rsv) protein g.
11/28/2002	WO2002094854A2 P.aeruginosa mucoid exopolysaccharide specific binding peptides
11/28/2002	WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002	WO2002094851A2 Peptide vaccines against group a streptococci
11/28/2002	WO2002094845A2 Method for stabilising of nucleic acids
11/28/2002	WO2002094780A2 Kinases and phosphatases
11/28/2002	WO2002094342A2 Compositions for protein delivery via the pulmonary route
11/28/2002	WO2002094325A2 Cytotoxic cd44 antibody immunoconjugates
11/28/2002	WO2002094317A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	WO2002094316A2 Method of preparing aluminium-hydroxide gel
11/28/2002	WO2002094315A2 Myostatin immunoconjugate and its use for immunisation
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002094312A1 Polypeptides derived from human telomerase reverse transcriptase
11/28/2002	WO2002094228A1 Prevention and treatment of allergies by helminthic regulation of ige
11/28/2002	WO2002094199A2 METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
11/28/2002	WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094190A2 Heterologous protection induced by immunization with invaplex vaccine
11/28/2002	WO2002094184A2 Vaccines for the treatment of autoimmune disease
11/28/2002	WO2002093998A2 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
11/28/2002	WO2002080648A3 Mucosal boosting following parenteral priming
11/28/2002	WO2002074345A3 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
11/28/2002	WO2002072008A9 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002066619A9 Methods of treating inflammation, particularly diabetes
11/28/2002	WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002045745A3 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002032936A9 E. histolytica-specific antibodies and clinical uses thereof
11/28/2002	WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002	WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002	WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001082897A3 Liposome drug delivery
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177839 Microprojection array having a beneficial agent containing coating
11/28/2002	US20020177697 Immunity to trypanosomatids species
11/28/2002	US20020177694 Composition containing immunogenic peptide for use in the treatment, diagnosis and prevention of viral diseases and cancers
11/28/2002	US20020177693 Chromatographic method for high yield purification and viral inactivation of antibodies
11/28/2002	US20020177614 Preventing neural tissue damage caused by adenosine-diphosphate- ribosylation of eucaryotic elongation factor-2 (EF-2)
11/28/2002	US20020177573 Ligand for bacterial toxins, which is capable of selective interaction with the beta-sheet-hinge-alpha-helix structure of the superantigens.
11/28/2002	US20020177569 Tuberculosis vaccine
11/28/2002	US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002	US20020177553 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177551 Mammalian cell receptor useful in the treatment of cancer which binds tumor associated lipids wherein said binding induces anergy or apoptosis in said T cells and antigen presenting cells.
11/28/2002	US20020177550 Administering to the subject a therapeutically effective amount of a form of soluble Receptor for Advanced Glycation Endproducts (RAGE).

1 ... 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 ... 1823